Mahindra Lifespaces Signs MoU With Tata Projects Aims To Enhance Construction Efficiency And Scalability

  

Mahindra Lifespace Developers Limited (MLDL), the real estate and infrastructure development arm of the Mahindra Group, today announced the signing of a Memorandum of Understanding (MoU) with Tata Projects Limited, one of India’s sustainable technology led engineering, procurement, and construction (EPC) companies. The partnership aims to enhance construction efficiency and scalability starting with Mahindra Vista Project in Kandivali, Mumbai.

 

Under this MoU, Tata Projects will serve as a strategic construction partner to deliver execution for Mahindra Lifespaces’ project development. The partnership will focus on leveraging advanced construction technologies, sustainable material usage, and digitally enabled project management systems to ensure timely delivery, consistent quality, and reduced carbon footprint. This partnership aligns with Mahindra Lifespaces’ commitment to operational excellence and Tata Projects’ expertise in delivering world-class, future-ready infrastructure.

 

Speaking at the signing of the MoU, Amit Kumar Sinha, Managing Director & CEO, Mahindra Lifespace Developers Ltd., said “This partnership marks a significant milestone in our journey towards scaling Mahindra Lifespaces’ portfolio while staying true to our sustainability and quality-first ethos. Tata Projects’ proven execution excellence and innovative construction practices will help us accelerate delivery timelines and enhance customer experience. Together, we aim to redefine the benchmarks for sustainable, tech-driven construction in India’s real estate sector.”

 

Vinayak Pai, Managing Director & CEO, Tata Projects Ltd., added “This collaboration underscores our shared commitment to building responsibly using cutting-edge technologies and efficient engineering processes. At Tata Projects, we believe in creating infrastructure that is not only future-ready but also environmentally conscious. We are delighted to partner with Mahindra Lifespaces — a pioneer in sustainable and customer-centric real estate — to deliver projects that set new benchmarks in quality, safety, and sustainability. Together, we aim to create a model of excellence for modern, environment-conscious urban development in India.”

GIFT Nifty Sets An All-Time High Monthly Turnover Of US $103.45 Billion In The Month Of October 2025

·         GIFT Nifty recorded the highest-ever monthly turnover of US $103.45 billion (INR 9,16,576 Crs. equivalent) with 2.06 million contracts during October 2025

GIFT Nifty, which stands as a new benchmark to the growth story of Indian equity market, recorded a new milestone and has added yet another feather in its cap in terms of achieving All-Time High Monthly Turnover of US $103.45 billion as on 30th October 2025. This remarkable feat surpasses its previous record of US $102.35 billion set in May 2025.

 

This milestone reflects the growing global interest and trust in the GIFT Nifty as a benchmark for the India’s growth story.  We are glad to witness the success of GIFT Nifty and express our sincere gratitude to all the participants for their overwhelming support and making GIFT Nifty a successful contract.

 

Trading turnover on NSEIX has been growing exponentially since commencement of a full-scale operation of GIFT Nifty on July 3, 2023. Since the first day of full-scale operations, GIFT Nifty has witnessed a total cumulative volume of over 52.71 million contracts with total cumulative turnover of US $2.39 trillion till October 30, 2025.

Indian Fharma Fair – 14th Edition Set To Transform Bangalore’s Pharma Landscape

The 14th edition of the Indian Fharma Fair, South India’s biggest pharmaceutical exhibition, will be held at Palace Grounds, Gate No. 9, Princess Shrine, Bengaluru. The event will be inaugurated by Sri Raghunath Reddy R, President, and A.K. Jeevan, General Secretary, Karnataka Chemists and Druggists Association (KCDA), which also supports the exhibition.

The two-day fair will feature over 70 leading pharmaceutical manufacturing and marketing companies from across India, including Medicant Group, Psychocare Health, Zee Laboratories, Medicef Pharma, Matteo Formulations, Kedar Drugs & Pharmaceutical, Elkos Healthcare, Xieon Lifesciences, and many others.

Aimed at connecting the entire pharma ecosystem, the exhibition offers a dynamic platform to showcase innovations, technologies, and business opportunities across pharmaceuticals, nutraceuticals, ayurvedic and herbal products, wellness, veterinary care, and cosmetics.

This year’s edition will focus on pharma franchising, third-party and contract manufacturing, generic medicines, and export opportunities, bringing together manufacturers, marketers, medical professionals, wholesalers, and distributors under one roof.

Mr. B.S. Bhandari, Director of Indian Fharma Fair, remarked, “We’re proud to host the fair’s fourteenth edition and the second in Bengaluru. This large-scale event unites pharma companies nationwide, helping visitors discover new products, suppliers, and partnerships while contributing to Karnataka’s economic growth.”

The Indian Pharma Fair continues to serve as a hub of innovation, collaboration, and opportunity, driving growth and excellence across India’s pharmaceutical sector.

For more details, visit: www.indianfharmafair.com

Apollo Cancer Centres Turns Chocolates Into Health Reminders With ‘Check-Olate’—A Sweet Pause That Could Save Your Life

A treat that’s more than just a chocolate, reminding every woman to take a moment for herself.

 

This Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) has launched a unique initiative that blends indulgence with awareness through ‘Check-Olate’, a sweet treat that carries an even sweeter reminder: take a moment for yourself.

 

According to GLOBOCAN, breast cancer remains the leading cause of cancer incidence and mortality among Indian women, accounting for 13.5% of all new cancer cases and 10.6% of total cancer deaths. Despite this growing burden, screening rates remain alarmingly low, with only 1.6% of women aged 30–69 years having ever undergone screening (NCBI). Recognising the urgent need for greater awareness and proactive prevention, ACCs aims to normalise self-care through Check-Olate and empower women to make breast self-examination a monthly ritual, helping them take charge of their health early.

 

Mr Dinesh Madhavan President - Group Oncology & International, Apollo Hospitals Enterprise Limited. said, “When women are healthy, nations prosper. Every woman’s well-being is a force multiplier that strengthens families, communities, and the economy. Closing the women’s health gap could add an estimated 1 trillion dollars annually to the global economy by 2040. At Apollo, we see women’s health as a national priority and a shared responsibility. Through Apollo Cancer Centres, we are advancing early detection, enabling timely intervention, and building a culture where proactive care is the norm. The ‘Check-Olate’ initiative is another purposeful step in this mission, reminding women that self-care is not a privilege; it is power, and it fuels a healthier, stronger, and more prosperous India.”

 

Ms. Pooja Gandhi, said, “Everyone loves chocolate; it brings comfort, warmth, and a bit of joy into our day. What makes Check-Olate truly special is how it takes something so universally loved and turns it into a gentle reminder for women to care for themselves. Through something as simple as a bar of dark chocolate, it encourages regular breast self-examination. I think that’s such a creative and thoughtful way to turn awareness into action and empower women to truly understand their health.”

 

Each bar of dark chocolate (Check-Olate) features a QR code that, when scanned, opens an animated video demonstrating a step-by-step guide on breast self-examination.

 

Dr. Jayanti Thumsi, Lead & Robotic Surgeon, Breast Oncology, Apollo Cancer Centres, Bangalore, said, “When it comes to breast cancer, early detection isn’t just important, it’s lifesaving. At ACC, we’ve witnessed firsthand how timely screening and awareness have helped save numerous women through early-stage diagnosis and treatment. Check-Olate is our way of turning a moment of indulgence into a reminder for proactive health. Dark chocolate, known for its antioxidant and mood-enhancing benefits, becomes a comforting messenger of care, reminding every woman that a simple self-examination, just a few minutes a month, can make all the difference. By making this message accessible and relatable, we aim to replace fear with awareness and action.”

 

Beyond its symbolic warmth, Check-Olate thoughtfully uses dark chocolate for its proven wellness benefits. According to NCBI, dark chocolate is rich in antioxidants and flavonoids that help reduce inflammation, support heart health, and uplift mood. Research further highlights its positive effects on skin, cardiovascular, and metabolic health, making it not just a treat for the senses but a meaningful reminder that caring for your health can also be a source of comfort.

 

‘Check-Olate’ is more than a Breast Cancer Awareness Month initiative; it’s a movement to help women reclaim control over their well-being through simple, meaningful rituals. By turning a moment of indulgence into a nudge for self-care, Apollo Cancer Centres redefines how healthcare communication can connect with empathy, creativity, and purpose.

Vedanta Limited Reports Record Revenue And EBITDA In Q2 And H1FY26

·        Profit before exceptional items jumps 13% YoY to ₹5,026 crores

·         Records highest ever second quarter Revenue at ₹39,218 crore, up 6% YoY

·         Achieves highest ever[1] second quarter EBITDA at ₹11,612 crore, up 12% YoY supported by margin expansion of 69 bps to 34%

Vedanta Limited (BSE: 500295 & NSE: VEDL) today announced its Unaudited Consolidated Results for the second quarter and half year ended 30th September 2025. Vedanta delivered robust financials with profit after tax before exceptional items jumping 13% YoY to ₹5,026 crores. The company clocked the highest ever* second quarter and first half EBITDA of ₹11,612 crores, up 12% YoY. Vedanta’s EBITDA margin improved by 69 bps to 34%† YoY. The company also recorded the highest ever second quarter revenue at ₹39,218 crores, up 6% YoY.

Vedanta’s Net Debt to EBITDA ratio improved from 1.49x to 1.37x, with cash and cash equivalents of ₹ 21,481 crore. The company’s Return on Capital Employed (ROCE) improved by 347 bps YoY to 26. Credit ratings for Vedanta have been reaffirmed at AA by both CRISIL and ICRA.

Vedanta invested ~USD 0.9 billion in growth capex in the first half. The company clocked record quarterly alumina production of 653 kt, up 31% YoY, and record cast metal aluminium production of 617 kt, up 1% YoY. Notably, BALCO produced its first metal from India’s largest 525 kA Smelter. At the alumina refinery at Lanjigarh (Odisha), Vedanta produced the first alumina from the expansion project. The company expanded merchant power capacity by 1.3 GW through Meenakshi Energy and Athena Power.

Vedanta’s zinc operations in India reported their highest-ever second quarter mined metal production at 258 kt, up 1% YoY, along with its lowest-ever Q2 cost of production at $994/t in last 5 years, lower by 7% YoY. The company’s international zinc operations witnessed a 38% jump in mined metal production to 60 kt. The Iron Ore, Steel and Copper segment delivered a strong performance, with iron ore production up 48% YoY at 0.1 Mnt, record pig iron production of 238 kt, up 26% YoY, and ore production at FACOR increasing 23% YoY to 47 kt.

 

Commenting on Q2FY26 results, Mr. Arun Misra, ED, Vedanta, said, “Our H1 FY26 performance reflects Vedanta’s resilience. We delivered 8% YoY EBITDA growth in a period marked by uncertainties and lower prices of key commodities that we deal with versus the annual average of FY25. This performance is on the back of our disciplined approach, focusing on volume growth and cost reduction across businesses. We delivered record production of Aluminium, Alumina, Zinc MIC in our international operations, Pig Iron and power generation.  Alongside, we delivered strong progress on new projects, including commissioning of 1.3 GW of new power plant capacities, first metal production from new BALCO smelter, first alumina from 1.5 MTPA train 2 at Lanjigarh refinery and start of 160 KTPA Roaster at Debari. Supported by this increased production capacity and the recovery in commodity prices, Vedanta is well positioned to deliver its best performance in FY26, with full year EBITDA surpassing the historic best EBITDA of ~USD 6bn delivered in FY22”.

 

Mr. Ajay Goel, CFO, Vedanta, said “This quarter, we achieved the highest-ever second quarter revenue of ₹ 39,218 crore, growing by 6% YoY. We also achieved our record second quarter EBITDA of ₹11,612 crore, reflecting 12% YoY growth with EBITDA margin expanding by 69 bps YoY to 34%. Our PAT before exceptional stands at ₹ 5,026 crore​, up 13% YoY. Staying true to our shareholder commitment, we also declared a dividend of Rs. 16 per share during the quarter. We have further improved our leverage. Our Net Debt to EBITDA ratio stands at 1.37x, improving from 1.49x last year. The reaffirmation in credit rating at AA by both Crisil and ICRA highlights our financial strength and markets’ confidence in the Vedanta’s growth story.”

 

2QFY26 ESG Highlights

 

§  ESG Leadership: Hindustan Zinc became the first Indian company to join the International Council on Mining and Metals—a prestigious global alliance of companies recognized for excellence in responsible mining practices.

§  Environmental: Across our operations, we planted over two lakh saplings, reinforcing our dedication to environmental stewardship. In Barmer, our rainwater harvesting initiatives enabled the collection of 0.23 million kilolitres, contributing to sustainable water management.

§  Social Front: Our outreach programs have now impacted over 27.5 million women and children, while 1.56 million families benefited from our skilling initiatives. Additionally, we signed an ₹85 crore MoU to restore heritage sites in Rajasthan, furthering our commitment to cultural preservation and community development.

Consolidated Financial Performance –                                               

(In ₹ crore, except as stated)

 

Particulars	2Q	2Q	% Change YoY	1Q	1H	1H
	FY2026	FY2025		FY2026	FY2026	FY2025
Revenue from operations	39,218	37,171	6%	37,434	76,652	72,410
Other Operating Income	650	463	40%	390	1040	988
EBITDA	11,612	10,364	12%	10,746	22,358	20,639
EBITDA Margin1	34%	34%	0%	35%	35%	34%
Finance cost	2,110	2,667	(21%)	2,026	4,136	4,889
Investment Income	701	722	(3%)	779	1480	1464
Exploration cost write off	187	43	-	757	944	140
Exchange Gain/ (Loss)- Non- operational and others	(133)	85	-	135	2	45
Profit before depreciation and taxes	9,882	8,461	17%	8,877	18,759	17,118
Depreciation & Amortization	2,868	2,696	6%	2,824	5,692	5,427
Profit before tax	7,015	5,765	22%	6,053	13,067	11,691
Tax Charge/ (Credit)	1,988	1,298	53%	1,596	3,584	2,129
Profit After Taxes before exceptional items	5,026	4,467	13%	4,457	9,483	9,562
Exceptional Items	(1,547)	1136	-	-	(1547)	1136
Profit After Taxes	3,479	5,603	(38%)	4,457	7,936	10,698

 

1Excludes custom smelting at copper business & one-off gain in Q2FY26

§  Revenue:

o   Consolidated revenue at ₹39,218 crore, up 6% YoY driven by higher LME, premia and forex gain partly offset by lower volume

o   The revenue is up 5% QoQ largely on account of higher LME, premia, forex gain and higher volume

§  EBITDA and EBITDA Margin:

o   EBITDA increased by 12% YoY to ₹11,612 crore mainly driven by higher premiums and forex benefit partially offset by higher cost and lower volume

o   EBITDA is higher by 8% QoQ mainly driven by higher premiums, forex benefit and higher volume partially offset by higher cost

o   EBITDA margin[3] at 34%, up 69 bps YoY

§  Depreciation & Amortization: 

o   Depreciation & Amortization at ₹2,868 crore increased 6% YoY and 2% QoQ mainly at Zinc International due to increased production

§  Finance Cost:

o   Finance cost is lower 21% YoY mainly due to lower interest rates and higher 4% QoQ majorly due one-offs in 1QFY26

§  Investment Income:

o   Investment Income is lower 3% YoY due to change in investment mix, and lower 10% QoQ due to higher interest on income tax refund in 1QFY26

§  Taxes:

o   ETR is 28% as compared to 26% in 1QFY25

§  Profit After Tax

o   PAT is ₹ 3,479 crore

§  Leverage, liquidity, and credit rating:

o   Gross debt at ₹ 83,544 crore as on 30th September 2025

o   Net debt at ₹ 62,063 crore as on 30th September 2025, implying Net debt to EBITDA ratio of ~ 1.37x

o   Cash and cash equivalents position remains strong at ₹ 21,481 crore. The Company follows a Board-approved investment policy and invests in high quality debt instruments with mutual funds, bonds, and fixed deposits with banks

o   Both ICRA and CRISIL have reaffirmed AA rating for Vedanta Limited